I. Introduction:
Glycated hemoglobin or glycosylated hemoglobin (hemoglobin A1C, HbA 1c , A1C, or Hb 1c ; sometimes also HbA1c) is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. 1 Hemoglobin A1c was first separated from other forms of hemoglobin by Huisman and Meyering in 1958 using a chromatographic column. 2 It was first characterized as a glycoprotein by Bookchin and Gallop in 1968 . 3 Its increase in diabetes was first described in 1969 by Samuel Rahbar et al. 4 The reactions leading to its formation were characterized by Bunn and his coworkers in 1975. 5 The use of hemoglobin A1c for monitoring the degree of control of glucose metabolism in diabetic patients was proposed in 1976 by Anthony Cerami, Ronald Koenig and coworkers. 6 It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose. 1 Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serve as a marker for average blood glucose levels over the previous months prior to the measurement. 1 Ketoamine reactions between glucose and other sugars and free amino groups on the alpha and beta chain lead to glycated forms of hemoglobin. 1 Only glycation of the N-terminal valine of the beta chain imparts sufficient negative charge to the hemoglobin molecule to allow separation by charge-dependent techniques. The charge-separated hemoglobin is collectively referred to as hemoglobin A 1 (HbA 1 ). 1 The major form of HbA 1 is hemoglobin A 1c (HbA 1c ), where glucose is the carbohydrate. This form comprises 4-6% of total hemoglobin. The remaining HbA 1 species contain fructose 1,6-diphosphate (HbA 1a1 ), glucose 6-phosphate (HbA 1a2 ), and an unknown carbohydrate moiety (HbA 1b ). The hemoglobin A 1C fraction is abnormally elevated in diabetic patients with chronic hyperglycemia.
1 Some laboratories measure the sum of these glycohemoglobins (GHbs) and report the total as hemoglobin A 1 , but more laboratories are converting to the more intricate but highly specific HbA 1c assay. 1 Methods for measuring Hb A1c include electrophoresis, cation exchange chromatography, boronate affinity chromatography, and immunoassays. Because GHbs circulate within red blood cells whose life span lasts up to 120 days, they generally reflect the state of glycemia over the preceding 8-12 weeks, thereby providing an improved method of assessing diabetic control. 1 The accuracy of HbA 1c values can be affected by hemoglobin variants or derivatives-the effect depending on the specific hemoglobin variant or derivative and the specific assay used.
Even though several studies on glycated hemoglobin has been done using other methods of assaying HbA 1c , literature search has revealed that there has not been any study in the South-east geopolitical region of Nigeria on glycated hemoglobin using the D10 -HPLC platform machine hence the need for this study.
Aims and Objectives:
1. To determine the pattern of Glycated hemoglobin seen in a patient population at the Federal Medical Center Umuahia using the D-10 HPLC machine. 2. To use findings from this study to make appropriate recommendations that would improve on Glycated hemoglobin screening policies in other Health institutions in Nigeria.
II. Methodology.
This is a descriptive study carried out at the medical outpatient department of the Federal Medical Center (FMC), Umuahia, Abia state, a 1000 bed tertiary health facility located in the South-east geopolitical region of Nigeria. Federal Medical Center Umuahia receives referral from neighboring towns like Aba, IkotEkpene and all the local government areas within Abia state. It was a prospective study where consecutive patients who presented at the general outpatient clinic between March and May 2013 were recruited. Sociodemographic data was documented in a questionnaire, blood sample was collected and the chromatographic patterns of their Glycated Hbs were obtained using the D-10 TM Hbk HPLC Testing system (Bio-Rad laboratories). The American Diabetic Association (ADA) 2010 criteria were used in categorizing patients 7 . Statistical analysis was done using SPSS v 16.
Principle of the D-10 Test:
HbA1c, the glycohemoglobin of interest, is formed in two steps by the nonenzymatic glycation of HbA. The first step is the formation of an unstable aldimine (labile A1c, or pre-A1c), a reversible reaction between the carbonyl group of glucose and the N terminal valine of the β-chain of hemoglobin. 8 Labile A1c formation is directly proportional to the blood glucose concentration. During red blood cell circulation, some of the labile A1c is converted (Amadori rearrangement) to form a stable ketoamine, HbA1c. 9 The D-10 Hemoglobin A1c Program is based on chromatographic separation of HbA1c on a cation exchange cartridge. Separation is optimized to minimize interferences from hemoglobin variants, labile A1c, and carbamylated hemoglobin. 8 The D-10 Hemoglobin A1c Program utilizes principles of ion-exchange high-performance liquid chromatography (HPLC). 8 The samples are automatically diluted on the D-10 and injected into the analytical cartridge. The D-10 delivers a programmed buffer gradient of increasing ionic strength to the cartridge, where the hemoglobins are separated based on their ionic interactions with the cartridge material. 8 The separated hemoglobins then pass through the flow cell of the filter photometer, where changes in the absorbance at 415 nm are measured. The software performs reduction of raw data collected from each analysis. Two-level calibration is used for quantitation of the HbA1c values. A sample report and chromatogram are generated for each sample. The A1c peak is shaded. This area is calculated using an exponentially modified Gaussian (EMG) algorithm that excludes the labile A1c and carbamylated peak areas from the A1c peak area. 
Sample collection:
Whole blood specimens were collected, with standard venipuncture technique, in a 4 ml vacuum collection tube containing EDTA (purple top tube). The samples were sent to the laboratory the same day of collection.
III. Results

Demographic distribution of the study population:
A total of seventy (70) patients made up of 31 (44.3%) males and 39 (44.3%) females were seen within the study period. All the study subjects were adults with majority of them (24.3%) between the age group of 20-30 years. Table 1 below shows the age and gender distribution of the study population. A total of three patients (4.3%) were less than 20 years while four patients (5.7%) were more than 70 years. Table 3 above shows the distribution of the study population according to the history of Type 2 Diabetes Mellitus.
IV. Discussion:
HbA1c is the most widely used index to monitor glycaemic control during a period of approximately three months and strongly correlates with the mean blood glucose level. The Diabetes Control and Complications trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) were large trials that demonstrated that HbA 1c levels are directly related to the risk of complications of diabetes, stroke and ischaemic heart disease. 10, 11 As HbA 1c is also a strong predictor of new onset diabetes mellitus, the American Diabetes Association now recommends this test in the diagnosis of diabetes mellitus and for identifying prediabetes 7 . The American College of Endocrinology (ACE) and American Association of Clinical Endocrinologists (AACE) perceive that HbA 1c should not be the primary criterion for the diagnosis of diabetes mellitus and that it should be used in conjunction with fasting plasma glucose and/or oral glucose tolerance tests. 12 The International Diabetes Federation and American College of Endocrinology recommend HbA 1c values below 48 mmol/mol (6.5%), while American Diabetes Association recommends that the HbA 1c be below 53 mmol/mol (7.0%) for most patients. 13 Twenty three (33.8%) of the study population were known to have Type 2 DM while 45 (66.2%) of these patients were not known diabetic patients. Sixteen (69.6%) of the twenty-three patients with diabetes had HbA 1c values greater than 7% indicating poor glycaemic control while seven had HbA 1c values less than 7% which indicates optimal glycaemic control. This is similar to the prevalence of 75% reported by Hasimah et al 14 in a study done in Malaysia to access the control of HbA 1c among Type 2 diabetes mellitus patients attending an urban health clinic. A lower prevalence of 40.7% was reported by Miyar Otero et al 15 in Sao Paolo, Brazil in a study on the socio-demographic and clinical characteristics of a diabetic population at a primary level health care center. D'souza et al 16 in Oman reported that 50% of all diabetics in their study had HbA 1c value of more than 7%. This clearly shows that there is preponderance of poor glycaemic control among known diabetic patients. In this study, majority of the patients (88.9%) not known to have diabetes had HbA 1c values less than 7%, however five (11.1%) of the patients who were not previously known to have diabetes had HbA 1c levels greater than 7%. This is higher than the value of 3% reported by Bernal-Lopez et al 17 in Southern Europe.
V. Conclusion:
This study revealed that 69.6% of the type 2 diabetes mellitus patients attending the medical outpatient clinic had poor diabetic control while 11.1% of the patients who were not previously known to have diabetes had elevated HbA 1c levels. Thus, more thought should be given to the importance of multi professional team education in diabetic patient care, with a view to: intensifying the strategies to obtain good glycaemic control; establishing a permanent means of communication between institutional health professionals and users, especially in the initial/adjustment phase of the diabetes treatment; reviewing the criteria established by health institutions regarding return visits, especially in the initial/adjustment phase of the diabetes treatment; involving the family and/or significant relatives in the education program, turning them into a collaborator in diabetic user care; and, finally, developing intervention research with diabetic users that encourage changes in habits and lifestyles, and permitting to understand what factors interfere and/or facilitate the achievement. The National Health Insurance policy should be strengthened and implemented in order to assist the poor and socially disadvantaged in getting adequate healthcare.
Limitations: Many factors that can influence HbA 1c levels (e.g. co-morbid conditions, physical activity index, genetically inherited hemoglobinopathies, income, marital status, employment, health literacy, social support system) have not been studied.
